M. Kathleen Behrens - Mar 7, 2022 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for M. Kathleen Behrens
Stock symbol: SRPT
Transactions as of: Mar 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/8/2022, 07:04 PM
Previous filing: Jan 4, 2022
Next filing: Mar 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Award	$0	+2.95K	+2.18%	$0.00	138K	Mar 7, 2022	Direct	F1
holding	SRPT	Common Stock						10K	Mar 7, 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Award	$0	+5.08K		$0.00	5.08K	Mar 7, 2022	Common Stock	5.08K	$80.42	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023.